4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:细胞因子、转录因子、miRNA及疾病标志物试剂
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Stable_cell_line > Signosis/NFAT Luciferase Reporter NIH 3T3 Stable Cell Line /SL-0029-FP/1 Ea
商品详细Signosis/NFAT Luciferase Reporter NIH 3T3 Stable Cell Line /SL-0029-FP/1 Ea
Signosis/NFAT Luciferase Reporter NIH 3T3 Stable Cell Line /SL-0029-FP/1 Ea
Signosis/NFAT Luciferase Reporter NIH 3T3 Stable Cell Line /SL-0029-FP/1 Ea
商品编号: SL-0029-FP
品牌: signosisinc
市场价: ¥42000.00
美元价: 25200.00
产地: 美国(厂家直采)
公司:
产品分类: 稳转细胞株
公司分类: Stable_cell_line
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

Description:

 NFAT Responsive Luciferase Reporter NIH/3T3 Stable Cell Line is derived from mouse fibroblast, and stably express firefly luciferase reporter gene under the control of NFAT response element.  This cell line is an ideal cellular model for monitoring the activation  of Calcium Signaling Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown.

Principle:

NFATs are a family of transcriptional factors that play an important role in immune response as well as in the development of cardiac, skeletal muscle, and nervous systems.  NFATs are regulated by calcium signaling. Through calcium activation of the phosphatase calcineurin, NFATc proteins translocate from the cytoplasm into the nucleus, where they cooperate with other proteins to mediate gene expression. Nuclear import of NFAT is blocked by kinases such as PKA and GSK3. NFATs are also implicated in breast cancer.  Signosis has established a NFAT luciferase reporter cell line that has been stably transfected with a NFAT-luciferase reporter construct. Via the analysis of luciferase, the cell line can be employed to monitor the cellular changes of NFAT activities that are triggered by stimulation, compound treatment, enforced gene expression or gene knockdown. 

The cell line is established by transfection using a pTA-NFAT-luciferase reporter vector, which contains NFAT binding sites, a minimal promoter upstream of the firefly luciferase coding region, along with hygromycin expression vector followed by hygromycin selection.  The hygromycin resistant clones were subsequently screened for PMA+ionomycin-induced luciferase activity.

 

Principle behind TF luciferase reporter.  TF luciferase reporter stable cell line utilizes artificial promoter constructs to drive luciferase expression.  The promoter region can consists of multiple repeats of a cis-element TF binding site, a DNA fragment from the promoter region of a known TF downstream gene, or a DNA fragment containing putative/known TF binding sites.  There are several ways that a TF can be activated, such as through extracellular stimuli or through intracellular signaling pathways.  Once activated, the TF translocates to the nucleus and often interacts with relevant co-factors to drive gene expression.  Once luciferase is expressed, it can generate light in an enzymatic assay and the amount of light measured is positively correlated with the level of TF activation.

 

Data:

 

 

 

 

 

 

 

 

 

 

 

 

Analysis of NFAT Luciferase Reporter NIH/3T3 Stable Cell Line.  The cells were seeded on a 96-well plate for overnight with DMEM including 10% FBS. The cells then were treated with or without 10ng/ml PMA and 1uM ionomycin in DMEM and 0.1% FBS for 16 hours.  More than 5 fold increase in luciferase activity was detected when compared to untreated cells.

 

品牌介绍
Signosis 是一家专业的生物分析供应商,致力于基于微孔板分析技术的生命科学研究产品的开发、生产和销售。Signosis 成立于2007年,坐落于世界研发中心--美国硅谷的中心地带。公司专注于细胞因子、转录因子、miRNA及疾病标志物等重要调控因子和标志物的研究,基于自有专利技术,开发完成400多种先进而独特的用于发现、筛选和分析的生命科学研究产品。Signosis 产品销售遍布北美、欧洲、亚洲及中东等主要国家和地区,客户涵盖美国国立卫生研究院、哈佛大学、耶鲁大学等著名研究机构以及众多制药公司